A Phase III Trial with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Ablynx
Start Date
February 1, 2016
End Date
October 30, 2017
Administered By
Medicine, Hematology
Awarded By
Ablynx
Start Date
February 1, 2016
End Date
October 30, 2017